Colgate-Palmolive (NYSE:CL) Sets New 12-Month High – Still a Buy?

Colgate-Palmolive Company (NYSE:CL – Get Free Report) reached a new 52-week high during trading on Monday. The stock traded as high as $101.26 and last traded at $101.2930, with a volume of 982,436 shares traded. The stock had previously closed at $99.67.

Recent Colgate-Palmolive Headlines

These are some of the CL headlines that stood out recently:

  • Positive Sentiment: Zacks Research raised its FY2026 EPS estimate to $3.91 from $3.85 and its FY2027 and FY2028 forecasts to $4.06 and $4.38, respectively. It also lifted estimates for several quarters, including Q3 2028. The revisions point to improving earnings expectations, although the FY2026 forecast remains just below the $3.92 consensus. Zacks Research Has Bullish Forecast for CL FY2026 Earnings
  • Neutral Sentiment: A comparison with Kimberly-Clark highlighted Colgate-Palmolive’s leading oral-care position and pet-nutrition business as potential growth strengths, but offered no new company-specific financial announcement. Colgate-Palmolive vs. Kimberly-Clark: Which Household Name Deserves Your Investment Dollars?
  • Negative Sentiment: Zacks also trimmed some quarterly estimates, including Q1 and Q2 2027 and Q1 and Q2 2028, suggesting expectations are not uniformly improving. Separately, an executive vice president sold $401,677 of CL shares; insider selling can weigh on sentiment, though the report provides no context on the transaction. Insider Selling: Colgate-Palmolive EVP Sells $401,677.00 in Stock

Analyst Upgrades and Downgrades

A number of research firms have commented on CL. TD Cowen boosted their price target on shares of Colgate-Palmolive from $90.00 to $97.00 and gave the stock a “hold” rating in a research report on Monday, November 2nd. Sanford C. Bernstein reaffirmed a “market perform” rating on shares of Colgate-Palmolive in a research report on Thursday, August 13th. UBS Group boosted their price objective on Colgate-Palmolive from $106.00 to $112.00 and gave the stock a “buy” rating in a report on Monday, November 2nd. Raymond James Financial boosted their target price on shares of Colgate-Palmolive from $100.00 to $102.00 and gave the company an “outperform” rating in a research note on Monday, August 3rd. Finally, Deutsche Bank restated a “buy” rating and set a $101.00 price target (up from $99.00) on shares of Colgate-Palmolive in a report on Monday, August 3rd. Thirteen equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $101.22.

Get Our Latest Report on Colgate-Palmolive

Colgate-Palmolive Stock Performance

The company has a debt-to-equity ratio of 11.23, a quick ratio of 0.63 and a current ratio of 0.96. The stock’s 50-day simple moving average is $90.94 and its two-hundred day simple moving average is $90.29. The stock has a market cap of $80.67 billion, a price-to-earnings ratio of 39.80, a price-to-earnings-growth ratio of 4.51 and a beta of 0.31.

Colgate-Palmolive (NYSE:CL – Get Free Report) last issued its quarterly earnings results on Friday, October 30th. The company reported $0.97 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.93 by $0.04. Colgate-Palmolive had a return on equity of 607.88% and a net margin of 9.65%. The company had revenue of $5.37 billion for the quarter, compared to the consensus estimate of $5.34 billion. During the same period last year, the business posted $0.91 earnings per share. The firm’s revenue was up 4.6% compared to the same quarter last year. Analysts forecast that Colgate-Palmolive Company will post 3.92 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, November 13th. Shareholders of record on Tuesday, October 20th were issued a $0.53 dividend. The ex-dividend date of this dividend was Tuesday, October 20th. This represents a $2.12 annualized dividend and a yield of 2.1%. Colgate-Palmolive’s dividend payout ratio is 83.14%.

Insider Transactions at Colgate-Palmolive

In other news, COO Panagiotis Tsourapas sold 19,938 shares of the company’s stock in a transaction that occurred on Wednesday, November 4th. The stock was sold at an average price of $98.74, for a total value of $1,968,678.12. Following the sale, the chief operating officer directly owned 9,111 shares in the company, valued at approximately $899,620.14. This represents a 68.64% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider John Hazlin sold 23,376 shares of the company’s stock in a transaction on Wednesday, November 4th. The shares were sold at an average price of $99.15, for a total value of $2,317,730.40. Following the completion of the sale, the insider owned 27,021 shares in the company, valued at $2,679,132.15. This trade represents a 46.38% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 77,414 shares of company stock valued at $7,613,786 in the last ninety days. 0.43% of the stock is owned by company insiders.

Institutional Trading of Colgate-Palmolive

Several hedge funds have recently modified their holdings of CL. Virginia Estate & Retirement Planning Advisors Inc. raised its holdings in shares of Colgate-Palmolive by 1,409.1% in the third quarter. Virginia Estate & Retirement Planning Advisors Inc. now owns 332 shares of the company’s stock valued at $28,000 after buying an additional 310 shares during the last quarter. Parvin Asset Management LLC bought a new stake in shares of Colgate-Palmolive during the 2nd quarter valued at $32,000. Park Place Capital Corp raised its position in shares of Colgate-Palmolive by 55.5% during the 2nd quarter. Park Place Capital Corp now owns 356 shares of the company’s stock valued at $33,000 after acquiring an additional 127 shares during the last quarter. Gould Capital LLC grew its stake in shares of Colgate-Palmolive by 38.7% during the first quarter. Gould Capital LLC now owns 412 shares of the company’s stock worth $35,000 after purchasing an additional 115 shares during the period. Finally, Montgomery Financial Services LLC acquired a new stake in shares of Colgate-Palmolive during the second quarter worth $36,000. Institutional investors and hedge funds own 80.41% of the company’s stock.

About Colgate-Palmolive

(Get Free Report)

Colgate-Palmolive is a global consumer products company whose business spans oral care, personal care, home care and pet nutrition. Its products include toothpaste, toothbrushes, mouthwashes, soaps, shampoos, cleaning products and pet food. The company’s best-known brands include Colgate, Palmolive, elmex, Softsoap, Ajax and Hill’s Pet Nutrition. It sells products through retail and other channels in markets around the world. Founded in 1806 by William Colgate as a soap and candle business in New York City, the company has grown into an international manufacturer of household and personal care products.

Recommended Stories

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.